Medicine
Megestrol 40 mg/mL oral suspension
Megestrol 40 mg/mL oral suspension is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from heat.
Key facts
- Active ingredient (INN)
- Megestrol
- Brand
- Sold under the generic name
- Strength
- 40 mg/mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 3 trays, 4 trays, 5 trays and 29 more
- Manufacturers
- Natco PharmaIndiaStrides PharmaIndiaXttrium LaboratoriesPAI PharmaKesin PharmaPrecision DoseAmerican Health PackagingANI PharmaceuticalsAtlantic BiologicalsGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from heat.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02AB01 Megestrol
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 July 2001
- Identifiers
- RxCUI 860225DailyMed set ID 3169f883-4076-32ce-e063-6394a90a4925, d0ad931e-4e3e-48bf-9949-77d6971da6e6, 01119031-9943-4afb-8b45-cb71682f0482 +11NDC 0116-4011, 68094-063, 17856-0060 +11Application ANDA076721, ANDA075671, ANDA077404
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 69339-160-16 | Natco PharmaIndia | 31 July 2023 |
| 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 69339-160-17 | Natco PharmaIndia | 31 July 2023 |
| 5 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 69339-160-18 | Natco PharmaIndia | 31 July 2023 |
| 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 69339-160-19 | Natco PharmaIndia | 31 July 2023 |
| 240 mL in 1 bottle, plastic | 64380-160-01 | Strides PharmaIndia | 21 March 2022 |
| 480 mL in 1 bottle, plastic | 64380-160-02 | Strides PharmaIndia | 21 March 2022 |
| 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0121-0945-00 | PAI Pharma | 26 October 2021 |
| 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0121-0945-40 | PAI Pharma | 26 October 2021 |
| 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0121-1038-00 | PAI Pharma | 17 October 2025 |
| 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0121-1038-40 | PAI Pharma | 17 October 2025 |
| 240 mL in 1 bottle | 70954-896-10 | ANI Pharmaceuticals | 2 July 2024 |
| 480 mL in 1 bottle | 70954-896-20 | ANI Pharmaceuticals | 2 July 2024 |
| 237 mL in 1 bottle, plastic | 0116-4011-08 | Xttrium Laboratories | 28 March 2025 |
| 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0116-4011-11 | Xttrium Laboratories | 28 March 2025 |
| 480 mL in 1 bottle, plastic | 0116-4011-16 | Xttrium Laboratories | 28 March 2025 |
| 30 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0116-4011-30 | Xttrium Laboratories | 28 March 2025 |
| 40 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0116-4011-40 | Xttrium Laboratories | 28 March 2025 |
| 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 68094-063-61 | Precision Dose | 11 July 2022 |
| 3 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 68094-063-62 | Precision Dose | 11 July 2022 |
| 3 tray in 1 case / 10 cup, unit-dose in 1 tray / 20 mL in 1 cup, unit-dose | 68094-174-62 | Precision Dose | 11 July 2022 |
| 3 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 60687-916-08 | American Health Packaging | 5 January 2026 |
| 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 60687-916-56 | American Health Packaging | 5 January 2026 |
| 72 cup in 1 box / 10 mL in 1 cup | 17856-0060-3 | Atlantic Biologicals | 9 May 2024 |
| 50 cup in 1 box / 20 mL in 1 cup | 17856-0060-4 | Atlantic Biologicals | 9 May 2024 |
| 240 mL in 1 bottle, plastic | 51407-910-24 | Golden State Medical Supply | 22 April 2024 |
| 480 mL in 1 bottle, plastic | 51407-910-48 | Golden State Medical Supply | 22 April 2024 |
| 30 cup, unit-dose in 1 carton / 20 mL in 1 cup, unit-dose | 81033-150-43 | Kesin Pharma | 7 August 2025 |
| 40 cup, unit-dose in 1 carton / 10 mL in 1 cup, unit-dose | 81033-150-44 | Kesin Pharma | 7 August 2025 |
| 100 cup, unit-dose in 1 case / 10 mL in 1 cup, unit-dose | 81033-150-52 | Kesin Pharma | 7 August 2025 |
| 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0904-7577-18 | Major Pharmaceuticals | 15 January 2026 |
| 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0904-7577-72 | Major Pharmaceuticals | 29 December 2025 |
| 240 mL in 1 bottle, plastic | 68788-8714-2 | Preferred Pharmaceuticals | 12 July 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 August 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Megestrol
Clinical summary
Megestrol is a progestin indicated for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). It is available as oral suspension and tablets. MedsAcross supplies Megestrol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MegestrolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Megestrol Acetate prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Megestrol 40 mg/mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.